EDN1 and open-angle glaucoma: In another controlled clinical study on 52 POAG patients, those treated with GBE showed, after 3 months of treatment, a relevant decrease of endothelin-1 (ET1, responsible for peripheral vasoconstriction), resulting in increased flow-dependent vasodilation.